SB-205800

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSB-205800
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsAtrial FibrillationStrokeCentral Nervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAtrial FibrillationStrokeCentral Nervous System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A